Semler Scientific (NASDAQ:SMLR) Sets New 52-Week High – Still a Buy?

Semler Scientific, Inc. (NASDAQ:SMLR) shares hit a new 52-week high during mid-day trading on Thursday . The stock traded as high as $74.85 and last traded at $74.85, with a volume of 322944 shares trading hands. The stock had previously closed at $59.27.

Semler Scientific Stock Performance

The company has a 50-day moving average of $31.69 and a 200-day moving average of $30.51. The firm has a market capitalization of $462.48 million, a price-to-earnings ratio of 31.05 and a beta of 0.92.

Semler Scientific (NASDAQ:SMLR) last posted its quarterly earnings data on Monday, November 4th. The company reported $0.72 EPS for the quarter, beating the consensus estimate of $0.37 by $0.35. The business had revenue of $13.51 million for the quarter. Semler Scientific had a net margin of 27.00% and a return on equity of 20.31%.

Insider Transactions at Semler Scientific

In other Semler Scientific news, CEO Douglas Murphy-Chutorian sold 10,000 shares of the stock in a transaction on Thursday, August 29th. The shares were sold at an average price of $28.35, for a total value of $283,500.00. Following the completion of the sale, the chief executive officer now owns 60,220 shares in the company, valued at $1,707,237. This trade represents a 14.24 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. 30.20% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Semler Scientific

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Geode Capital Management LLC increased its holdings in shares of Semler Scientific by 10.5% in the third quarter. Geode Capital Management LLC now owns 135,959 shares of the company’s stock valued at $3,202,000 after purchasing an additional 12,964 shares during the last quarter. Jane Street Group LLC lifted its position in Semler Scientific by 72.3% during the third quarter. Jane Street Group LLC now owns 16,982 shares of the company’s stock worth $400,000 after acquiring an additional 7,126 shares during the last quarter. State Street Corp boosted its holdings in shares of Semler Scientific by 0.6% during the third quarter. State Street Corp now owns 118,223 shares of the company’s stock worth $2,784,000 after acquiring an additional 725 shares during the period. Verition Fund Management LLC acquired a new position in shares of Semler Scientific in the third quarter valued at approximately $251,000. Finally, Crawford Fund Management LLC bought a new position in shares of Semler Scientific during the third quarter worth approximately $883,000. Institutional investors own 49.37% of the company’s stock.

About Semler Scientific

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.